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Abstract. Discovering all the genetic causes of a phenotype is an important goal in functional ge-
nomics. In this paper we combine an experimental design for multiple independent detections of the
genetic causes of a phenotype, with a high-throughput sequencing analysis that maximizes sensitivity
for comprehensively identifying them. Testing this approach on a set of 24 mutant strains generated
for a metabolic phenotype with many known genetic causes, we show that this pathway-based phe-
notype sequencing analysis greatly improves sensitivity of detection compared with previous methods,
and reveals a wide range of pathways that can cause this phenotype. We demonstrate our approach
on a metabolic re-engineering phenotype, the PEP/OAA metabolic node in E. coli, which is crucial to
a substantial number of metabolic pathways and under renewed interest for biofuel research. Out of
2157 mutations in these strains, pathway-phenoseq discriminated just five gene groups (12 genes) as
statistically significant causes of the phenotype. Experimentally, these five gene groups, and the next
two high-scoring pathway-phenoseq groups, either have a clear connection to the PEP metabolite level
or offer an alternative path of producing oxaloacetate (OAA), and thus clearly explain the phenotype.
These high-scoring gene groups also show strong evidence of positive selection pressure, compared with
strictly neutral selection in the rest of the genome.
1. Introduction
Discovering what genes cause a specific phenotype poses several experimental and analytical chal-
lenges, and there are several approaches in the literature for causal gene identification including direct
identification of causal mutations from naturally evolving populations growing in the prescence of isobu-
tanol [38] [2] , using transposon insertions to detect antibiotic targets [49] , use of chemical mutagenesis
to produce randomly generated mutants and subsequent high-throughput sequencing to identify key mu-
tation [45] [55] [22] . In particular, the method described in [22] , called phenotype sequencing, combines
the last approach with sequencing techniques to produce more information at a substantially reduced
total cost. See [11] and [10] for more on pooling methods.
Many such methods, while successful, have substantial drawbacks in terms of efficiency and compre-
hensivity of detection, total labor required to create mutants and verify mutations as causal, and overall
cost. Unless the mutagenesis density is very low, there can be many mutations that must be checked; if
there is only a single mutation in each mutant, causes of complex phenotypes requiring more than one
mutation may be missed. Naturally evolved strains typically both have fewer mutations (10-20 typically)
and a larger fraction of these directly contribute to the phenotype [24] [50] [47] [29] [33] [6] , with in
some cases as few as 3 mutations per strain [23] [7] or more than 40 [48] . On the other hand, natural
evolution typically involves a mixture of many mutants competing with each other. Even small differ-
ences in selective advantage will tend to give a winner-take-all outcome, in which the “top” mutant takes
over the culture, and other causes of the phenotype are obscured. This can occur even over a relatively
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short period of competitive culture (illustrated in Fig. 1). Hence if mutants are allowed to compete,
detection of smaller contributors to the phenotype can be washed out by the growth of other mutants.
This means that only some of the causes of a particular phenotype will be detected. In particular, if
there is a “trivial” way to get the phenotype, this can obscure the interesting, non-obvious causes of the
phenotype.
While mutagenesis can aid the production of mutants with the desired phenotype, it also elevates the
total number of mutations in each strain (often 50 - 100 mutations [39] [31] , of which perhaps only
one actually causes the phenotype). Dissecting these many candidate mutations experimentally can be
laborious, so we employ statistical methods to detect which mutations are most likely to be causal.
Given these challenges, it would be very useful to have reliable high-throughput methods for compre-
hensively identifying all the genetic causes of a phenotype. Three features seem crucial for this goal.
First, sufficient mutagenesis coverage is required to hit all the potential causes of the phenotype. Note
this may require mutating two or more genes simultaneously to achieve the desired phenotype. For a gene
to be identified with any kind of statistical significance in a high-throughput (genome-wide) analysis, the
“target” set of mutations in a gene that can actually cause the phenotype must be hit not just once but
multiple times in independent strains. Second, the different mutant strains (representing independent
mutagenesis events) must be screened non-competitively, e.g. by either picking only one colony from each
independent experiment, or by forgoing long growth rescue in liquid medium to avoid multiple colonies
arising from genetically identical daughter cells of a single mutant. This ensures that the different strains
with the phenotype will be independent mutation events that represent an unbiased sampling of the di-
verse possible causes of the phenotype. High-throughput sequencing of the independent mutant strains,
yielding the total number of times a gene is independently “hit” by mutations across all the strains, can
then directly reveal genes that cause the phenotype [22] . We refer to this bioinformatic approach as
“phenotype sequencing”. The results of the first phenotype sequencing experiment were further verified
in the study by Minty et al [38] , which found specific causal mutations in many of the genes identified
by phenotype sequencing (and also verified partially by [2] ; see also [43] ). We argue now that pheno-
type sequencing is self-validating and also present strength of selection measures to further statistically
validate results.
Third, to attain sensitive and comprehensive discovery of the causal genes, the analysis must be able
to combine signals across multiple genes that function together, e.g. in the same pathway. When multiple
genes in a pathway can cause the same phenotype, this “splits” the signal (concretely, the number of
observed mutations) among them, making it much harder to detect. For example, our first phenotype
sequencing analysis did not obtain a statistically significant score for some genes that are known to cause
the phenotype, even though they were relatively highly ranked (due to having more mutations than
expected by random chance) [22] . Combining signals from multiple such genes in a pathway greatly
improves sensitivity and hence allows for comprehensive discovery.
To assess the possibility of attaining these goals, we first developed a “pathway-phenoseq” analysis
that combines mutation signals across each specified pathway. For this first test, we used pathway
information from the EcoCyc database of functionally associated genes in E. coli [12] . Second, we tested
its ability to discover the multiple genetic causes of a metabolic phenotype which is known to involve
many genes and pathways. Third, in addition to validating its results against the experimental literature,
we also developed bioinformatic validation methods based on gene clustering and independent measures
of positive selection.
As an experimental test, we sought a phenotype that involves many pathways and where existing ex-
perimental literature could validate the results of our analysis. We therefore chose a metabolic phenotype,
namely recovery of ability to grow on glucose by E. coli lacking the Phosphoenolpyruvate carboxylase
(PPC). Metabolic engineering of the pyruvate - phosphoenolpyruvate (PEP) - oxaloacetate (OAA) node
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Figure 1. 1000 Simulations of the Wright-Fisher Selective Dynamics [18] of a
Randomly Mutagenized Population.
A. (Top) a simulation of 26 strains of various fitnesses that grow exponentially from a founder population of
individual mutants to a carrying capacity under Wright-Fisher selection dynamics. The results of a single
simulation show that one mutant dominates the population after a small number of generations. Note diversity
is lost due not only to selection, but also genetic drift.
B. (Middle) As reproduction and selection proceeds, the mean number of distinct strains decreases very quickly.
On average half of the strains are lost after just 6-7 generations.
C. (Bottom) Similarly, the mean Shannon entropy [8] of the population distribution also decreases quickly. This
differs from (B) in that the population proportions are also taken into account.
has long been studied as a way of modifying the energy balance of the cell [5] [28] [35] . Phospho-
enolpyruvate carboxylase (PPC) carboxylates PEP to OAA while releasing inorganic phosphate. Phos-
phoenolpyruvate carboxykinase (PEPCK) decarboxylates OAA and activates it to PEP using ATP as
a substrate. PEPCK is reversible in some organisms and the reverse PEPCK reaction is more energy
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efficient than the PPC reaction because it conserves the phosphate from PEP by generating ATP. In
E. coli, however, PEPCK is not reversible under normal conditions. Recently, with the increased focus
on renewable resources from microbes, optimization of the PEP/OAA metabolic node has received re-
newed interest. Much of the interest has focused on increasing the production of succinate (a high value
carboxylic acid of industrial relevance) in E. coli and other microbes. In recent studies PPC has been
supplemented or replaced with pyruvate carboxylase (PYK) [3] , and more often with PEPCK [17] ,
which increases the ATP pool of the cell. This can lead to higher levels of succinate production from
a variety of feedstocks [14] . The use of PEPCK and the resulting higher ATP concentration has also
been exploited to increase production of malate, OAA [40] or fumarate [52] and even the amount of
recombinantly expressed proteins [27] .
Overexpressing either a native or heterologous pepck gene is one way to compensate for the knockout
of ppc and rescue an OAA auxotroph strain. However, a number of other pathways affect OAA levels
and flux through the PEP node.
Selection for growth in glucose medium of ppc- mutants has been studied via naturally evolved mutants,
resulting in the creation of two mutant strains [19] . After 45 days of growth and selection, these mutants
had growth rates and glucose consumption rates very similar to the wild type strain, more than double
the ppc- strain on day 0. While the underlying genetic causes were not determined in this study, it
was found that metabolic flux through the glyoxylate shunt (aceA and aceB) increased and that there
was variable transcription of several genes, including decreased expression of ptsH and ptsI, subunits
of PEP-dependent phosphotransferase systems (PTS). The glyoxylate shunt is an alternative route for
the cell to make OAA. Decreased expression of the PTS systems is likely to increase PEP levels, as
the cell will use sugar transport pathways that do not require PEP. This is consitent with a study in
which mutations in PTS were found using a laboratory evolution setup selecting for increased growth and
succinate production [13] . The mutations increased flux through PEPCK in the non-native direction [13]
. In accordance with Le Chateliers principle, increasing the level of cellular PEP leads to higher reverse
PEPCK activity. Similarly, high PEP levels could also drive flux through the glyoxylate shunt. Without
extensive modeling of the metabolic network of the cell it is hard to predict a priori which mutations
would be most beneficial to raising PEP levels.
As a more fundamental study of the paths that can circumvent PPC, we designed a very simple
selection, not focused on succinate production, but rather looking at the many ways that E. coli can
replenish OAA levels without PPC. A ppc− strain cannot grow on glucose alone because there is no
anaplerotic supply of OAA to replenish the TCA cycle. Unlike previous reports, we did not eliminate
pflB and therefore allowed for mutants that could supply OAA through means other than PEPCK (for
example through TCA intermediates). We mutagenized the ppc− strain and selected for growth on
glucose. By performing 24 independent mutagenesis and selection experiments we produced 24 separate
mutant strains, identified mutations via pooled sequencing, and identified genetic causes via by pathway-
phenoseq and gene-phenoseq.
2. Results
Sequencing of Independent Mutants. Using growth on glucose medium as a selection, 24 mutants
with the desired phenotype were produced. The genomic DNA was pooled into 8 libraries each consisting
of exactly three strains. These libraries were tagged, combined, and sequenced in a single lane of a high-
throughput Illumina Hi-Seq sequencer. The resulting fragments were filtered, aligned to the reference E.
coli K-12 substr. MG1655 genome sequence, and scanned for sequence variants. Sequencing produced
145 million reads of 100 basepairs each for a total of 14.5 Gb of genomic sequence, of which approximately
118 million reads successfully demultiplexed (had an identifiable tag) and aligned to the reference genome.
From the pooled libraries, we identified 2157 SNPS (1450 nonsynonymous, 707 synonymous) after filtering
for quality and strand bias (see methods). These SNPs showed a strong preference for GC-sites in line
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with the mutagenesis spectrum of NTG [21] . SNPs were detected in 1348 genes; 1012 genes had one or
more nonsynonymous mutations.
Pathway-Phenoseq Analysis. We developed a method for scoring individual pathways, based on the
number of non-synonymous mutations occurring in genes in each pathway (see Method for details).
As a comprehensive set of E. coli pathway annotations, we used the EcoCyc Functionally Associated
Groups database, totaling 536 groups [12] , of which 336 were hit by non-synonymous mutations in our
sequencing dataset. (For simplicity, we will refer to these EcoCyc Functionally Associated Groups as
“pathways”). We applied our scoring method (which we will refer to throughout as “pathway-phenoseq”)
to all 336 pathways, and ranked them by their p-values (Table 1). After the Bonferroni multiple hypothesis
correction, the top five pathways (containing 12 genes total) were statistically significant.
Table 1. Top 10 gene groups ranked by pathway-phenoseq p-value (Bonferroni
corrected for 536 tests)
Group Genes p-value (phenoseq)
PD04099 aceK iclR 2.01× 10−39
CPLX0-2101 malE malF malG malK
lamB
2.84× 10−9
ABC-16-CPLX malF malE malG malK 7.17× 10−8
PD00237 malS malT 4.29× 10−4
GLYCOGENSYNTH-
PWY
glgA glgB glgC 4.25× 10−3
CPLX-155 chbA chbB chbC ptsH ptsI 0.145
PWY0-321 paaZ paaA paaB paaC
paaD paaE paaF paaG
paaH paaJ paaK
0.146
RNAP54-CPLX rpoA rpoB rpoC rpoN 0.53
APORNAP-CPLX rpoA rpoB rpoC 0.62
APORNAP-CPLX rpoA rpoB rpoC rpoD 0.71
Overall, the top seven pathway-phenoseq scoring pathways either have a clear connection to the PEP
metabolite level or offer an alternative path of producing oxaloacetate (OAA), and thus fit the ppc−
growth phenotype (Figure 2). PD04099 (aceK and iclR) regulates the glyoxylate shunt [9] , [36] ,
which is an alternative way of producing OAA. By deregulating this pathway acetyl-CoA can be used
to regenerate OAA instead of being completely consumed by the TCA cycle [30] . In fact iclR has
been deliberately mutated for biotechnology applications to increase flux through the glyoxylate shunt
and increase yields of biomass or desired products [51] . The next three association groups (CPLX0-
2101, ABC-16-CPLX, and PD00237) relate to the maltose transport pathway. If deregulated the maltose
transporter can transport glucose using ATP as energy, instead of PEP like the PTS system [4] . Therefore
deregulation of this group would increase PEP levels. The fifth association group GLYCOGENSYNTH-
PWY identified involves mutations in the glycogen synthesis pathway. Any mutations that decrease
activity of this pathway would increase glucose and ATP levels of the cell and therefore decrease the
PEP requirement of glucose transport. These mutations are again correlated with increasing cellular
PEP levels. The chb (chitin PTS transport) pathway CPLX-155 (association group six) is another
sugar transport pathway that requires PEP [26] . Any mutations that downregulate or deactivate this
pathway lead to an increased pool of PEP in the cell, again consistent with the selection performed.
The genes ptsH and ptsI encode general subunits of PTS systems that are required for transport and
phosphorylation of all sugars [44] . Therefore, PEP-dependent sugar transport in general is affected by
these mutations. In addition to hits in ptsHI, mutations were also found in crr, the regulator responsible
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for PEP-dependent transporters. We found mutations in sugar specific subunits of several other PTS
systems, however we would need more data to boost the signal and determine which are significant. The
seventh association group (PWY0-321) found in our selection encompasses genes of the phenylacetate
degradation pathway [15] . Like the first association group, this pathway answers the selection not by
increasing PEP levels, but instead by supplying OAA through another TCA intermediate (See Figure
2). The final product of the phenylacetate degradation pathway is succinyl-CoA, a TCA intermediate
that can be metabolized to OAA. All of the identified hits are relevant to OAA levels, either by affecting
PEP pools or by supplying direct precursors of OAA. Many of the hits identified here were not among
those that have been rationally explored by metabolic engineers interested in the PEP/OAA node. This
indicates that there is great value in performing high throughput evolution and sequencing experiments
such as these to identify new avenues of metabolic modifications relevant to a pathway of interest. The
final pathways in Table 1 consist of rpoABC and rpoD and N genes which affect gene expression globally.
Mutations in these genes can have widespread effects on gene expression. We do not know the precise
mechanisms of how these mutations may affect the observed phenotype.
Comparison with Gene-phenoseq. By contrast, gene-phenoseq identified only three of these genes
(iclR and aceK in pathway PD04099; malT in pathway PD00237) as statistically significant (Table 2).
Thus pathway-phenoseq detected more than twice as many causal pathways for this phenotype, and four
times as many genes as the gene-phenoseq scoring.
Table 2. Top 20 hits ranked by Bonferroni corrected gene-phenoseq p-value computed
on non-synonymous SNPs
Gene p-value
iclR 1.39× 10−25
aceK 8.43× 10−14
malT 4.81× 10−4
malE 0.045
yjbH 0.088
rplL 0.18
ydfJ 0.18
pgi 0.21
yhcA 0.78
tyrS 0.82
yjaG 0.82
yeeN 0.82
tig 0.85
glgB 0.88
fdhF 0.89
gntT 1.04
dbpA 1.11
ydfl 1.16
lysC 1.18
xylE 1.22
Bioinformatic Validation Tests. As an additional test of the entire set of top scoring pathways, we
computed a p-value for evidence of positive selection (Ka/Ks > 1) within this set (Table 3). Whereas
the phenoseq scoring is based on the total number of mutations in a region, the Ka/Ks is based on the
ratio of non-synonymous vs. synonymous mutations (note that the latter are not considered by the
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Figure 2. Schematic of metabolic pathways affected by Ppc knockout (dotted line). The
:math:‘text{Ppc}ˆ-‘ strain requires additional oxaloacetate to grow. Growth is achieved
through direct synthesis of oxaloacetate by alternative pathways such as the glyoxylate
shunt or *pck, or through an increase of PEP levels, which drives flux through these
pathways. The top seven mutated pathways identified by pathway phenotype
sequencing are shown in red. It has been shown that Ppc knockouts cause increased
flux through the glyoxylate shunt [41] , consistent with our observed mutations in AceK
and IclR. Mutations in PtsI have previously been observed in response to a
growth-based selection for increased succinate production, in a scenario where Pck
overexpression was also observed [53] . Similarly, deletion of ptsH, which also
deactivates the PTS system and increases the intracellular PEP pool, has also been
shown to increase succinate yields [54] .*
phenoseq scoring function). The Ka/Ks ratio for the total dataset of 2157 SNPs was 1.0026, consistent
with neutral selection, as expected from random mutagenesis. We therefore computed a p-value for the
null hypothesis that mutations in the top pathways are drawn from the same background distribution
as the total set of mutations (i.e. neutral) using the Fisher Exact Test (see Methods for details). The
top 10 pathway-phenoseq pathways contained a total of 103 non-synonymous mutations vs. only 21
synonymous mutations, yielding a p-value of 3.38 × 10−5. This is strong evidence of positive selection.
Even leaving out the genes detected by gene-phenoseq (iclR, aceK, malT ), the p-value is 5.12 × 10−3.
Furthermore, this evidence of positive selection extends throughout the top ten pathways. For example,
if one leaves out pathways 6 through 10, the p-value becomes weaker (4.34× 10−4, or again leaving out
iclR, aceK, malT, 0.056). Indeed the p-value becomes stronger (smaller p-value) with each additional
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pathway added to the analysis, indicating that each pathway shows evidence of positive selection. Note
that at the level of single-gene analysis, only one gene (iclR with 19 non-synonymous mutations and 1
synonymous mutation) could be detected as showing statistically significant evidence of positive selection
(p = 3.1× 10−3); other genes simply did not have enough total mutation counts to attain significance.
Table 3. Positive Selection evidence for Top 10 gene groups
Pathway cumulative p-value excluding iclR, aceK, malT
PD04099 0.0037 N/A
CPLX0-2101 0.0044 0.28
ABC-16-CPLX 0.0027 0.28
PD00237 0.0027 0.29
GLYCOGENSYNTH-PWY 0.0020 0.19
CPLX-155 0.00043 0.056
PWY0-321 0.000068 0.011
RNAP54-CPLX 0.000043 0.0063
APORNAP-CPLX 0.000043 0.0063
APORNAP-CPLX 0.000034 0.0051
It is interesting to ask what fraction of the genes in these pathways show evidence of causing the
phenotype. It is evident (e.g. from the known experimentally validated genes) that real causal genes
are present far below the 0.05 significance threshold of gene-phenoseq scoring (also found to be the
case in a previous phenotype sequencing experiment [22] .) To assess this, we took the top 50 gene-
phenoseq genes, and asked what pathways were strongly enriched (Table 4). Given a top list of genes,
one can assess whether they cluster within specific subgroups of a standard functional annotation using
the hypergeometric p-value test [20] . This analysis identified statistically significant clustering within
three EcoCyc pathways. Furthermore, six of the top ten pathways matched the top 10 pathway-phenoseq
pathways. These data indicate that at least 9 of the genes in these pathways contribute causally to
the phenotype (since they were individually detected among the top 50 gene-phenoseq hits). Only 28
pathways intersected the top 50 list.
Table 4. Top 10 gene groups ranked by hypergeometric p-value (Bonferroni corrected
for 28 tests)
Group Genes Genes in top 20 p-value (hyper-
geometric)
ABC-16-CPLX malF malE malG malK 4 0
PD04099 aceK iclR 2 0
CPLX0-2101 malE malF malG malK lamB 4 6.875× 10−9
CPLX-63 torY torZ 1 0.0043
PD00237 malS malT 1 0.0043
ABC-42-CPLX alsA alsB alsC 1 0.013
APORNAP-CPLX rpoA rpoB rpoC 1 0.013
GLYCOGENSYNTH-PWY glgA glgB glgC 1 0.013
SECE-G-Y-CPLX secE secG secY 1 0.013
CPLX0-221 rpoA rpoB rpoC fecI 1 0.025
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Causal Mutations Analysis. Finally, we sought to estimate the number of mutations in each group
that actually help cause the phenotype (“causal mutations”). In principle, one can estimate this from
the observed bias towards non-synonymous mutations (compared with that expected under neutral se-
lection as observed in the total dataset). Specifically, we assume that all causal mutations must be
non-synonymous, whereas non-causal mutations are drawn from the background mixture of synonymous
+ non-synonymous mutations (i.e. neutral selection). We can then estimate the fraction of mutations in
each pathway that are causal, since the observed fraction of non-synonymous mutations fo in a pathway
will reflect the mix θ of causal vs. non-causal mutations:
fo = θ + (1− θ)fn
where fn = 1448/2157 is the fraction of non-synonymous mutations observed in the entire dataset (which
almost exactly matches that expected for neutral selection). Then
θ =
fo − fn
1− fn
We then estimated the number of causal mutations in a pathway as Nc = Nθ, where N is the total
number of mutations observed in the pathway (Table 5). It is striking, for example, that the estimated
number of causal mutations in the top pathway (iclR + aceK ) precisely equals the number of independent
mutant strains sequenced (24). This suggests that each strain with this phenotype was mutated once in
this pathway. The number of causal mutations estimated in the remaining pathways ranged from 4 to 9,
suggesting that at least one additional mutation in these other pathways was present in each strain. For
each pool of three strains, at least three nonsynonymous mutations were observed in the (iclR + aceK )
pathway, so our data is consistent with the hypothesis that there must be a mutation in this pathway to
achieve the phenotype.
Table 5. Estimated Causal Mutations in the Top 10 gene groups
Group Synonymous Muta-
tions
Non-synonymous
Mutations
Causal Mutations
PD04099 5 34 24
CPLX0-2101 / ABC-
16-CPLX
6 18 6
PD00237 3 11 5
GLYCOGENSYNTH-
PWY
3 10 4
CPLX-155 0 7 7
PWY0-321 1 11 9
RNAP54-CPLX /
APORNAP-CPLX /
APORNAP-CPLX
3 12 6
3. Discussion
These data show first that pathway-phenoseq greatly improves sensitivity and comprehensive discovery
of the genetic causes of a phenotype, over gene-phenoseq. It detected a statistically significant signal for
more than two times as many pathways, and an even greater proportion of genes. Second, our results
indicate that independent (non-competitive) mutant strains do indeed reveal a wide variety of genetic
causes of a phenotype, in this case: regulators of the glyoxylate shunt; the maltose transport pathway;
the glycogen synthesis pathway; and the phosphotransferase system. Third, our analysis suggests that
the phenoseq approach is far more sensitive for detecting such “selection loci” than standard measures
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of selection such as Ka/Ks or dn/ds. For example phenoseq detected a single pathway with a p-value of
2 × 10−39 (Bonferroni- corrected), compared with a positive selection p-value on the same pathway of
0.0037 (not even Bonferroni-corrected).
We now consider some further implications and challenges in this work. First, it is evident that the
number of mutant strains sequenced both in this study (24) and the previous isobutanol tolerance study
(32) are inadequate for definitively identifying all genes that contribute to these phenotypes. That is,
our results (and other experimental studies) have shown clear evidence for a number of genes causing
this phenotype, that failed to attain statistical significance in the gene-phenoseq scoring, e.g. PEPCK
mutations were not statistically significant in our study. In many cases gene-phenoseq scoring ranked
these genes highly, but the sample size simply was not large enough to yield a strong p-value. This
reflects a fact about our two phenotypes which may apply generally to many other phenotypes: they are
complex, and involve many genes, more than can be reliably detected by gene-phenoseq with sequencing
of 30 mutant strains. It also illustrates why pathway-phenoseq is needed: in our (admitedly limited)
experience, inadequate sensitivity is the key factor limiting discovery.
Second, the same general approach should be applicable to other mutagens and types of mutations. As
a minor example, in the current study we did analyze promoter mutations (separately from coding-region
mutations), but did not find any significant results (data not shown). The same basic analysis should be
applicable to deletion mutations, transposon insert events and any other mutational process for which
one can build an adequate neutral model. In the worst case, one could simply obtain data for a control
set of strains (i.e. mutated but not screened for the phenotype), to provide an empirical model of the
mutational bias of the set of genes, that would be used as the null (non-target) model for scoring the
results observed after phenotype screening.
Third, it seems interesting to ask how many causal mutations are required to produce the phenotype.
We have presented a very simplistic way of estimating the number of mutations in each pathway that
are actually causal. This already seems to yield intriguing suggestions, for example that the top pathway
(glyoxylate shunt regulation) is mutated in essentially every strain that has the phenotype, and that
this is typically accompanied by a “second mutation” in another pathway. It seems likely that more
sophisticated approaches to this question will yield useful insights. This is but one example of exploring
positive selection signals (concretely, by taking synonymous mutations into account, which phenoseq
ignores). Another possible application of positive selection data is suggested by our Table 3: whereas
the total mutation dataset is unequivocally neutral (Ka/Ks=1), the top-ranking pathways show clear
evidence of positive selection (Ka/Ks > 1). Thus, it would be interesting to determine (via a robust
probabilistic analysis) how far down the list of top-ranked phenoseq pathways this positive selection
signal goes (i.e. where does it revert to neutrality). In principle, this could provide a measure of the
depth of phenotype selection in the dataset, independent of the phenoseq p-value.
For the specific phenotype under study, we found that there appears to be a causal mutation in the
regulatory pathway (iclR and aceK) of the glyoxylate shunt (aceA and aceB) in every strain (Table 5).
Once activated, the shunt is then driven by a secondary mutation in another pathway that alters the
levels of PEP and/or OAA in the cell. This is consistent with an earlier study [19] which produced
two (naturally evolved) ppc- mutants able to grow in a glucose medium, both of which had increased
flux through the glyoxylate shunt as well as decreased expression of ptsH or ptsI (our sixth ranked
pathway), however the mutants in that study were not sequenced, so it is not known which genes were
mutated. Moreover, selection strength analysis (Table 3) shows that there is evidence of positive selection
in pathways beyond the top phenotype sequencing ranked pathway (iclR + AceK). It may be the case
that the top pathway is effectively larger since it is potentially more likely that a causal mutation occurs
in a regulatory gene than in an enzymatic gene (which may have a far smaller active region). Regardless,
a mutation in the regulatory pathway is evidently not sufficient to induce the phenotype. Similarly, it is
possible that, in order to see PEPCK reversal, PEP levels must be significantly elevated and pck must be
deregulated. Our experiment may not have contained a large enough sample size to accommodate both
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of these requirements. In other studies the elevated PEP levels are often artificially achieved through
pflB knockouts.
Finally, we must consider organisms where pathway annotation is lacking (compared with the high
level of pathway annotation for E. coli). In principle, any source of functional groupings of genes (for
example “Rosetta Stone”, phylogenetic profiles and related non-homology approaches) could be used,
in the absence of human-curated pathway annotations. Another interesting possibility is to invert the
problem: given a diverse set of easily screenable phenotypes, one could systematically perform phenotype
sequencing on many such phenotypes, to obtain observed groupings of genes that appear to “function
together” in the sense of causing the same phenotype(s). Note that in contrast with a typical “functional
correlation” analysis (such as on expression levels), even seeing a pair of genes as correlated by a single
data point (i.e. both causing one phenotype) would actually be significant. Thus far fewer phenotypes
would have to be studied to obtain significant results, than for other functional correlation analyses such
as expression levels. Thus phenotype sequencing could itself be used as a high-throughput method for
finding functional groupings of genes in less well studied microbial organisms.
4. Methods
Bacterial strains and growth conditions. For strain construction and to prepare samples for NTG
mutagenesis strains were grown in standard Luria Bertani medium [46] . Under selective conditions
strains were grown in a modified M9 medium (6 g Na2HPO4, 3 g KH2PO4, 1 g NH4Cl, 0.5 g NaCl, 1
mM MgSO4, 1 mM CaCl2, 10 mg vitamin B1 per liter of water) containing 1% glucose.
Mutagenesis was performed on parent strain ppc−. This strain was generated by P1 transduction to
delete ppc from E. coli strain coli JCL16 (BW25113/F [traD36, proAB+, lacIq ZDM15]) [1] , using strain
JW3928 from the Keio collection as a P1 donor [16] . This strain is unable to grow on glucose minimal
medium.
NTG mutagenesis and selections. Random mutagenesis was performed with N-nitro-N-nitrosoguanidine
(NTG) as previously described [37] . Briefly, cultures of ppc− were grown to exponential phase in LB
medium, washed twice with 0.1M citrate buffer and then concentrated two-fold by centrifugation and
suspension in 0.1 M citrate buffer (pH 5.5). Samples of 2mL were exposed to N-nitro-N-nitrosoguanidine
(NTG) at a final concentration of 50 mg/ml for 30 minutes at 37C to reach a percentage kill of approx-
imately 50%. The cells were washed twice with 0.1 M phosphate buffer (pH 7.0) and grown in LB for
one hour. The cells were then challenged by plating on glucose minimal medium and grown at 37C for 3
days. This procedure was performed on 24 separate samples of ppc−, each of which was plated separately
to ensure genetically distinct populations of mutants. One colony from each separate NTG experiment
was selected, restreaked on selective medium plates to verify the phenotype and then cultured in liquid
medium to obtain genomic DNA.
DNA library preparation and sequencing. Bacterial genomic DNA was prepared from 24 mutant
strains using the DNEasy kit from Qiagen using the optional RNAse treatments. The isolated genomic
DNA from the mutant strains was pooled in 8 pools, each at a total concentration of 20ng/µL. Equal
amounts of DNA from 3 mutant strains were mixed in each of the 8 pools. The pooled samples were then
fragmented by sonication to an average size of 100250 bp and confirmed by gel electrophoresis. 8 tagged
genomic sequencing libraries (8 different indexes) were constructed using the TruSeq DNA Sample Prep
Oligo Kit following the low throughput protocols provided by the manufacturer (Illumina). The final
concentration of each of the 8 indexed libraries was measured by QuantiFluor assay and the 8 libraries
were mixed in equal proportion at a final concentration of 10nM. 100bp single end read sequencing was
carried out on a single lane of an Illumina Genome Analyzer HiSeq 2000 instrument by the UCLA Broad
Stem Cell Research Center High Throughput Sequencing Facility.
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Pathway-Phenoseq Analysis. Short read data were aligned to the reference E. coli genome (Genbank
accession NC 000913) using Novoalign (Novocraft, Selangor, Malaysia) in single-end mode. Sequence
variants were then called using samtools [34] mpileup and bcftools output to VCF format. Only sin-
gle nucleotide substitutions were found via this analysis, consistent with NTG mutagenesis. We then
employed our phenoseq software package to apply a succession of variant filters:
• we excluded variants with inadequate samtools quality scores. Specifically, we required a QUAL
value of greater than 90.
• we excluded reported variants with strong evidence of strand bias (i.e. the evidence for the variant
came primarily from reads in one direction but not the other). Specifically, we excluded variants
with a samtools AF1 p-value of less than 10−2. This eliminated a large number of variant calls
that appear to have been sequencing errors.
• we excluded variants with samtools allele frequency estimate greater than 50% in any given pool.
Concretely, each independent mutant strain is expected to have different mutations, so each
mutation should be present in only one out of three of the strains mixed together in one pool.
• we excluded variants that were found in multiple tagged pools. In all cases these were found in all
8 pools, indicating that they were parental strain mutations (i.e. differences versus the reference
genome sequence).
We then used the EcoCyc functionally associated gene groups to score pathways as follows:
• we only included non-synonymous mutations in the phenoseq analysis. Specifically, we used the
Pygr software package [32] to map the Genbank CDS annotations on the reference genome, to map
mutations to CDS (gene) intervals, and to determine their effect on the amino acid translation.
Mutations that did not map to a CDS, or did not alter the amino acid translation, were excluded.
• CDS-mapped mutations were mapped to each EcoCyc group using the EcoCyc database.
• The expected mutational cross-section λ for each EcoCyc group was calculated based on its GC
composition, and the total density of all observed mutations on GC sites vs. AT sites over the
whole genome.
• We computed a p-value for the null hypothesis that the observed mutations kobs in an EcoCyc
pathway were obtained by random chance, under a Poisson model
p(K ≥ kobs|non-target, λ) =
∞∑
K=kobs
e−λλK
K!
These calculations were performed with the scipy.stats module [25].
• We applied a Bonferroni correction to this p-value by multiplying by the total number of EcoCyc
pathways groups Ne = 536.
We performed positive selection tests on these EcoCyc pathway groups as follows:
• for a given set of one or more EcoCyc pathways, we obtained the countsNa, Ns of non-synonymous
vs. synonymous mutations in that set of pathways.
• We computed the p-value for obtaining this result under a neutral (i.e. Ka/Ks = 1), random
model:
p(m ≥ Na|n = Na +Ns, N,M)
where N is the total number of all observed synonymous + non-synonymous mutations in the
whole genome, and M is the total number of observed non-synonymous mutations in the whole
genome. Specifically, we computed this p-value using the one-tailed (“greater”) Fisher Exact Test
in R [42] .
• Note that since only a single p-value test was performed (on the top-ranked set of pathways), no
Bonferroni correction was applied.
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Similarly, we computed p-values for pathway “enrichment” among the top 50 gene-phenoseq genes
using the hypergeometric test, again computed using the Fisher Exact Test in R or scipy [25] , with a
Bonferroni correction corresponding to the number of pathways that this test was applied to.
All of our code is available under an open source license at https://github.com/cjlee112/phenoseq.
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